Soleno on Wednesday said the FDA approved its Vykat XR extended-release tablets for the treatment of hyperphagia, a chronic and life-threatening feeling of intense, persistent hunger, in people ages 4 ...

The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...

The U.S. Food and Drug Administration on Wednesday approved Soleno Therapeutics' drug to treat a rare genetic disorder, ...

Soleno Therapeutics gained approval from the Food and Drug Administration for its hyperphagia drug. The biopharmaceutical company focused on treating patients with rare diseases said Wednesday it got ...

While research suggests having a higher weight may increase your risk for certain conditions, people can be healthy at every ...

Nyxoah (NYXH) announced that the FDA has issued an approvable letter regarding the company’s pre-market approval application for the Genio ...

INSIDE INFORMATIONREGULATED INFORMATIONFDA Issues Nyxoah an Approvable Letter for its Genio® SystemMont-Saint-Guibert, Belgium – March 26, 2025, ...

The Senate on Tuesday night confirmed Marty Makary to be the Food and Drug Administration commissioner. Makary was easily ...

The day before announcing Zyn’s marketing authorization, FDA Center for Tobacco Products announced another proposed rule that could have a massive impact on public health: a product standard that ...

The FDA approved Humacyte’s lab-grown blood vessel Symvess despite internal warnings from agency scientists about its safety ...

CorMedix (NASDAQ: CRMD) Q4 2024 Earnings Call Mar 25, 2025, 8:30 a.m. ET Good day, and welcome to the CorMedix Inc.

Joining us today are Oncocyte President and CEO, Josh Riggs; Chief Science Officer, Ekke Schutz; and CFO, Andrea James. We ...